Bionova Capital

ExtremoChem is a chemical synthesis company dedicated to the development and commercialization of innovative small synthetic molecules designed for the stabilization of biological materials facing stress conditions. The company provides a comprehensive range of services, including accelerated stability studies, pH stability assessments, thermal stability assessments, and aggregation analysis. These services are aimed at supporting life science research organizations, as well as the pharmaceutical, biotech, agrochemical, and chemical industries. ExtremoChem's work enables the stabilization of medicines and proteins that are otherwise unstable at room temperature, facilitating their storage and use in various applications.

Delox is a Portuguese company focused on the design and development of bio-decontamination devices aimed at creating clean and biosafe environments. Founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, Delox specializes in automatic bio-decontamination robots and has developed a proprietary solid formulation of hydrogen peroxide, known as DeloxHP. This innovation allows for the efficient production of compact and cost-effective bio-decontamination devices, including the Delox Box, which is ready for market use. The company’s technology is applicable in various sectors, including the sterilization of medical devices, room bio-decontamination in hospitals and the food industry, as well as the decontamination of laboratory equipment and environmental test chambers. Delox aims to provide non-toxic solutions that effectively combat microorganisms, catering to the health, pharmaceutical, biodefense, and space industries.

SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on advancing treatment options for patients with chronic wounds. Founded in 2017, the company is developing Aurase, a hydrogel designed to enhance wound bed preparation through the application of a recombinant enzyme derived from maggots. This innovative approach aims to facilitate wound debridement, a crucial therapeutic procedure that removes dead, damaged, or infected tissue, thereby accelerating the healing process. By leveraging biomimicry and evidence-based medicine, SolasCure seeks to improve patient outcomes across various healthcare settings.

AdaptTech Ltd., established in 2015 and based in Birmingham, UK, is a biomedical company specializing in innovative, smart wearable technologies designed to enhance the lives of individuals with physical limitations, particularly those who have experienced lower limb loss. The company's flagship products include the INSIGHT Scanner, which rapidly creates a 3D model of prosthetic sockets; the INSIGHT Wearable, real-time bio-data tracker between the stump and socket; and the INSIGHT App, providing anytime access to results. AdaptTech aims to empower clinicians with improved socket fitting and monitoring methods, ultimately improving the quality of life for users.

Vaxdyn is a biotechnology company focused on the development of vaccines and immunotherapies aimed at preventing infectious diseases, particularly those caused by antibiotic-resistant pathogens. Utilizing innovative technology, Vaxdyn's vaccines incorporate antigens, immunomodulators, nanoparticles, and monoclonal antibodies to effectively combat bacterial infections. This approach helps healthcare professionals mitigate the public health impact of infections that are resistant to traditional treatments. The company actively engages with its customers through various communication channels, including phone, email, and online applications, to address inquiries related to their vaccine offerings.

CellmAbs, established in 2019 and headquartered in Lisbon, Portugal, specializes in developing therapies for glycoimmunology and oncology. As a spin-off from NOVA University of Lisbon, the company focuses on creating solutions for cancer treatment, immunotherapies, and glycobiology. CellmAbs has swiftly grown into an internationally experienced team, having produced several preclinical candidates targeting solid tumors by leveraging advanced knowledge of cancer-specific glycan targets.

CellmAbs, established in 2019 and headquartered in Lisbon, Portugal, specializes in developing therapies for glycoimmunology and oncology. As a spin-off from NOVA University of Lisbon, the company focuses on creating solutions for cancer treatment, immunotherapies, and glycobiology. CellmAbs has swiftly grown into an internationally experienced team, having produced several preclinical candidates targeting solid tumors by leveraging advanced knowledge of cancer-specific glycan targets.

SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on advancing treatment options for patients with chronic wounds. Founded in 2017, the company is developing Aurase, a hydrogel designed to enhance wound bed preparation through the application of a recombinant enzyme derived from maggots. This innovative approach aims to facilitate wound debridement, a crucial therapeutic procedure that removes dead, damaged, or infected tissue, thereby accelerating the healing process. By leveraging biomimicry and evidence-based medicine, SolasCure seeks to improve patient outcomes across various healthcare settings.

Delox is a Portuguese company focused on the design and development of bio-decontamination devices aimed at creating clean and biosafe environments. Founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, Delox specializes in automatic bio-decontamination robots and has developed a proprietary solid formulation of hydrogen peroxide, known as DeloxHP. This innovation allows for the efficient production of compact and cost-effective bio-decontamination devices, including the Delox Box, which is ready for market use. The company’s technology is applicable in various sectors, including the sterilization of medical devices, room bio-decontamination in hospitals and the food industry, as well as the decontamination of laboratory equipment and environmental test chambers. Delox aims to provide non-toxic solutions that effectively combat microorganisms, catering to the health, pharmaceutical, biodefense, and space industries.

AdaptTech Ltd., established in 2015 and based in Birmingham, UK, is a biomedical company specializing in innovative, smart wearable technologies designed to enhance the lives of individuals with physical limitations, particularly those who have experienced lower limb loss. The company's flagship products include the INSIGHT Scanner, which rapidly creates a 3D model of prosthetic sockets; the INSIGHT Wearable, real-time bio-data tracker between the stump and socket; and the INSIGHT App, providing anytime access to results. AdaptTech aims to empower clinicians with improved socket fitting and monitoring methods, ultimately improving the quality of life for users.

Anybrain is a technology company specializing in artificial intelligence and data processing. It develops an anti-fraud platform designed to enhance security and fairness in online gaming and esports. The platform uses machine learning algorithms to analyze user interaction patterns with computers via keyboard and mouse, enabling proactive detection of game fraud and abnormal behaviors.

Performetric is a real-time monitoring system that allows the management of mental fatigue in a non-invasive way that aims to develop leisure and work context-aware environments that may improve the quality of life, wellness, mental health and individual performance. Moreover, it also aims to support a better management of the employees and their work time. This translates into a positive impact in the organization’s productivity and an increased quality of life and better health of the employees.